← back to search
Michael Kragh
Houston Methodist
· US
Area of research
Oncology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Cetuximab, Panitumumab, Colorectal cancer, Medicine, KRAS, and Cancer.
h-index
—
citations
569
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
The genomic landscape of response to EGFR blockade in colorectal cancer
Nature
2015
cited by
492
position: middle
doi
Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer
Cancer Discovery
2015
cited by
77
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Josep Tabernero
· Medical Research Network
1
papers (2015–2015)
Rachel S. van der Post
· Radboud University Nijmegen
1
papers (2015–2015)
—
·
1
papers (2015–2015)
—
·
1
papers (2015–2015)
—
·
1
papers (2015–2015)
Rocio García‐Carbonero
· Research Institute Hospital 12 de Octubre
1
papers (2015–2015)
—
·
1
papers (2015–2015)
Guillem Argilés
· Vall d'Hebron Institut de Recerca
1
papers (2015–2015)
Susana Roselló
· Instituto de Salud Carlos III
1
papers (2015–2015)
Anthony W. Tolcher
· Texas Oncology
1
papers (2015–2015)
—
·
1
papers (2015–2015)
—
·
1
papers (2015–2015)
—
·
1
papers (2015–2015)
Amita Patnaik
· South Texas Accelerated Research Therapeutics
1
papers (2015–2015)
Rodrigo Dienstmann
· MedSIR (Spain)
1
papers (2015–2015)
Eric Van Cutsem
· KU Leuven
1
papers (2015–2015)
Andrés Cervantes
· Cervantes Institute
1
papers (2015–2015)
Marta Benavent
· Instituto de Biomedicina de Sevilla
1
papers (2015–2015)